SCYNEXIS INC
Datakwaliteit: 100%
SCYX
NASDAQ
Manufacturing
Chemicals
€ 1,02
▲
€ 0,01
(0,99%)
6 months return
—
Momentum
Neutral
5Y revenue growth
11,85%
Groei
Revenue Growth (5Y)
11,85%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)449,95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-21,28%
Boven sectorgemiddelde (-54,49%)
ROIC-27,48%
Net Margin-41,79%
Op. Margin-78,03%
Veiligheid
Debt / Equity
N/A
Current Ratio5,75
Interest Coverage-92,91
Waardering
PE (TTM|NTM)
-5,15 | -3,03
Onder sectorgemiddelde (-1,50)
P/B Ratio1,22
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 11,85% annually over 5 years — strong growth
Negative free cash flow of -5,28 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 438,10%
Price History
Financiële Trends
Koersdoel Analisten
3 analisten
Buy
+240.5%
upside to target
Huidig
€ 1,02
Consensus Target
€ 3,47
€ 3,00
Laag
€ 4,00
Hoog
Vooruitzicht
Forward K/W
-3,03
Forward WPA
-€ 0,33
Omzet Sch.
6,68 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,13
·
Rev Est: 77.000,0
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -€ 0,11 | -€ 0,14 | -€ 0,17 | € 0,25 | — | — |
| Estimate | -€ 0,19 | -€ 0,19 | -€ 0,20 | € 0,13 | -€ 0,13 | -€ 0,13 |
| Verrassing | +43,10% | +26,32% | +15,00% | +97,36% | — | — |
Growth
Rev 5Y: 11,85% · Earnings 1Y: N/A
Growth
Rev 5Y: 11,85% · Earnings 1Y: N/A| Revenue Growth (1Y) | 449,95% | Revenue Growth (3Y) | -61,66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11,85% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -21,28% · Net Margin: -41,79%
Profitability
ROE: -21,28% · Net Margin: -41,79%| Revenue (TTM) | 20,60 M | Net Income (TTM) | -8,61 M |
| ROE | -21,28% | ROA | -15,41% |
| Gross Margin | N/A | Operating Margin | -78,03% |
| Net Margin | -41,79% | Free Cash Flow (TTM) | -5,28 M |
| ROIC | -27,48% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 5,75
Safety
D/E: N/A · Current: 5,75| Debt / Equity | N/A | Current Ratio | 5,75 |
| Interest Coverage | -92,91 | Asset Turnover | 0,37 |
| Working Capital | 40,23 M | Tangible Book Value | 36,43 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -5,15 · EV/EBITDA: N/A
Valuation
P/E: -5,15 · EV/EBITDA: N/A| P/E Ratio | -5,15 | Forward P/E | -3,03 |
| P/B Ratio | 1,22 | P/S Ratio | 2,15 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 6,64 | Fwd Earnings Yield | N/A |
| FCF Yield | -11,92% | ||
| Market Cap | 44,31 M | Enterprise Value | 29,51 M |
Per Share
EPS: -0,17 · FCF/Share: -0,12
Per Share
EPS: -0,17 · FCF/Share: -0,12| EPS (Diluted TTM) | -0,17 | Revenue / Share | 0,46 |
| FCF / Share | -0,12 | OCF / Share | -0,12 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 61,37% · CapEx/Rev: N/A
Efficiency
FCF Conv: 61,37% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 61,37% |
| SBC-Adj. FCF | -8,35 M | Growth Momentum | 438,10 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20,60 M | 3,75 M | 140,14 M | 5,09 M | 13,16 M |
| Net Income | -8,61 M | -21,29 M | 67,04 M | -62,81 M | -32,87 M |
| EPS (Diluted) | -0,17 | -0,44 | 1,39 | -1,47 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -16,07 M | -37,12 M | 72,67 M | -85,76 M | -60,84 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 22,28 M | 26,41 M | 30,93 M | 27,26 M | 23,77 M |
| SG&A Expenses | 14,40 M | 14,46 M | 20,92 M | 62,96 M | 49,92 M |
| D&A | — | 0,0 | 580.000,0 | 606.000,0 | 379.000,0 |
| Interest Expense | 173.000,0 | 828.000,0 | 3,13 M | 5,20 M | 2,66 M |
| Income Tax | 0,0 | 151.000,0 | 138.000,0 | -4,70 M | -3,09 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 59,03 M | 90,64 M | 128,41 M | 87,81 M | 119,84 M |
| Total Liabilities | 9,65 M | 35,57 M | 55,45 M | 84,58 M | 78,58 M |
| Shareholders' Equity | 49,38 M | 55,08 M | 72,96 M | 3,23 M | 41,26 M |
| Total Debt | — | — | — | 34,39 M | 28,75 M |
| Cash & Equivalents | 21,26 M | 16,05 M | 34,05 M | 45,81 M | 104,48 M |
| Current Assets | 40,37 M | 72,18 M | 102,12 M | 79,06 M | 109,38 M |
| Current Liabilities | 5,73 M | 24,10 M | 16,30 M | 17,62 M | 13,62 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,2 | -1,5 |
| P/B | 1,2 | 1,6 |
| ROE % | -21,3 | -54,5 |
| Net Margin % | -41,8 | -41,5 |
| Rev Growth 5Y % | 11,9 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"SCYX","listing_kind":"stock","pathname":"/stocks/scyx","exchange":"NASDAQ","country":"US"}}